Return to search results
Meropenem
Meropenem is a prescription antibiotic used to treat serious bacterial infections. It comes as a powder for injection, administered intravenously in doses of 500 mg or 1 g per vial. Manufactured by WG Critical Care, LLC, it's a generic version approved under ANDA210773. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Meropenem is a prescription antibiotic used to treat serious bacterial infections. It comes as a powder for injection, administered intravenously in doses of 500 mg or 1 g per vial. Manufactured by WG Critical Care, LLC, it's a generic version approved under ANDA210773. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Meropenem", "mediaType": "text/html", "description": " Access the FDA dataset for Meropenem — ANDA 202106 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202106" } ] |
| identifier | ANDA202106 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "drug-safety", "fda", "health-care", "pharmaceuticals" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Meropenem |
